Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-16Clinical Trial Update: Retrospective Analysis of Lymphomas and Cancers Synchronous Occurrence in Picardy From 2007 to 2012
A retrospective observational analysis of the synchronous occurrence of lymphoma and other cancers in Picardy from 2007 to 2012. The trial h…
-
CLINICAL_TRIALS withdrawal · 2026-01-06Clinical Trial Update: Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating immune reconstitution monitoring and pneumococcal vaccination in patients treated with CAR-T cells has be…
-
CLINICAL_TRIALS withdrawal · 2025-09-10Clinical Trial Update: Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study [Phase 1]
This document reports the withdrawal of a Phase 1 trial evaluating the combination of nivolumab and ipilimumab in pediatric and young adult …
-
CLINICAL_TRIALS withdrawal · 2025-05-13Clinical Trial Update: A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies [Phase 1]
A Phase I trial of donor-derived 19-28z CAR T cells following allogeneic transplant for CD19 malignancies has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-21Clinical Trial Update: QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma [Phase 1]
A Phase 1 trial of CD19 t-haNK for diffuse large B-cell lymphoma has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-05-06Clinical Trial Update: Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M) [Phase 2]
A Phase 2 MATCH subprotocol trial testing nivolumab with relatlimab (BMS-986016) for LAG-3 positive tumors with mismatch repair deficiency h…
-
CLINICAL_TRIALS withdrawal · 2023-04-21Clinical Trial Update: A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 3]
A Phase 3 trial combining Zilovertamab with Ibrutinib for relapsed or refractory mantle cell lymphoma has been withdrawn.
-
EMA withdrawal · 2023-02-10EMA Application withdrawn: Aliqopa (copanlisib dihydrochloride) — Bayer AG
The EMA has withdrawn the application for Aliqopa (copanlisib dihydrochloride) by Bayer AG for its use in lymphoma subtypes including margin…
-
CLINICAL_TRIALS withdrawal · 2018-07-27Clinical Trial Update: Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies [Phase 1]
This Phase 1 trial of alisertib (MLN8237) in combination with brentuximab vedotin for relapsed/refractory CD30-positive lymphomas and CD30-p…
-
CLINICAL_TRIALS withdrawal · 2018-01-19Clinical Trial Update: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma. [Phase 3]
Phase 3 trial of romiplostim for chemotherapy-induced thrombocytopenia in adults with lymphoma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-26Clinical Trial Update: Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group
A clinical trial comparing continuous glucose monitoring (CGM) and oral glucose tolerance testing (OGTT) in relation to pancreas T2* MRI-det…
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia [Phase 1]
Phase 1 trial of RO4929097 in children with relapsed/refractory solid or CNS tumors, lymphoma, or T-cell leukemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-06-27Clinical Trial Update: Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) [Phase 1, Phase 2]
The Phase 1/2 trial assessing pembrolizumab in combination with chemotherapy for advanced lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-06-12Clinical Trial Update: Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma. [Phase 1, Phase 2]
A Phase 1/2 trial evaluated intratumoral dendritic cell vaccination combined with local radiotherapy in patients with recurrent lymphoma. Th…
-
CLINICAL_TRIALS withdrawal · 2017-05-15Clinical Trial Update: Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) [Phase 2]
Phase 2 trial evaluating SharkCore EUS-guided biopsy needle versus ProCore has been withdrawn. Sponsor: Johns Hopkins University; conditions…
-
CLINICAL_TRIALS withdrawal · 2017-04-21Clinical Trial Update: Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma [Phase 2]
A Phase 2 trial evaluating panobinostat with high-dose gemcitabine/busulfan/melphalan and autologous stem cell transplant for refractory/rel…
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: Delayed Effects of Treatment in Cancer Survivors (DETECS)
The DETECS clinical trial (NCT02067637) investigating delayed treatment effects in cancer survivors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-22Clinical Trial Update: Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma [Phase 1, Phase 2]
The Phase 1/2 trial of reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-05Clinical Trial Update: Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy [Phase 4]
Phase 4 clinical trial assessing changes in bone mineral density in lymphoma patients undergoing chemotherapy has been withdrawn. The study …
-
CLINICAL_TRIALS withdrawal · 2016-07-13Clinical Trial Update: EBUS-TBNA Versus EBUS-TBNB [NA]
A clinical trial comparing EBUS-TBNA to EBUS-TBNB has been withdrawn from the registry, per the sponsor Royal Brompton & Harefield NHS Found…
-
CLINICAL_TRIALS withdrawal · 2016-05-04Clinical Trial Update: Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating belinostat in combination with azacitidine, gemcitabine, busulfan, and melphalan with autologous stem-cell tran…
-
CLINICAL_TRIALS withdrawal · 2016-03-21Clinical Trial Update: Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants [Phase 1]
A Phase 1 trial of immunotherapy for Epstein-Barr virus–associated lymphoproliferative diseases in organ transplant recipients was withdrawn…
-
CLINICAL_TRIALS withdrawal · 2016-03-11Clinical Trial Update: Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating lamivudine and tenofovir for lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer [NA]
A clinical trial evaluating celecoxib for pain, weight loss, and weakness in advanced cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-25Clinical Trial Update: Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma [Phase 1, Phase 2]
The clinical trial of lenalidomide for previously untreated advanced-stage follicular lymphoma has been withdrawn.